Coronex Limited Filleted accounts for Companies House (small and micro)

0 false false false false false false false false false true false false false false false false No description of principal activity 2020-04-15 Sage Accounts Production Advanced 2020 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP SC659338 2020-04-15 2021-04-30 SC659338 2021-04-30 SC659338 bus:Director1 2020-04-15 2021-04-30 SC659338 bus:Director2 2020-04-15 2021-04-30 SC659338 core:WithinOneYear 2021-04-30 SC659338 bus:Director1 2021-04-30 SC659338 bus:Micro-entities 2020-04-15 2021-04-30 SC659338 bus:AuditExemptWithAccountantsReport 2020-04-15 2021-04-30 SC659338 bus:FullAccounts 2020-04-15 2021-04-30 SC659338 bus:SmallCompaniesRegimeForAccounts 2020-04-15 2021-04-30 SC659338 bus:PrivateLimitedCompanyLtd 2020-04-15 2021-04-30

COMPANY REGISTRATION NUMBER: SC659338

Coronex Limited

Filleted Unaudited Financial Statements

30 April 2021

Coronex Limited

Statement of Financial Position

30 April 2021

	Period from
	15 Apr 20 to
	30 Apr 21
	£
Current assets	2,120

Creditors: amounts falling due within one year	29,972
	--------
Net current liabilities	27,852
	--------
Total assets less current liabilities	( 27,852)

Accruals and deferred income	250
	--------
	(28,102)
	--------

Capital and reserves	( 28,102)
	--------

Notes to the financial statements

1. Directors' advances, credits and guarantees

During the period the directors entered into the following advances and credits with the company:

	30 Apr 21
	Balance brought forward	Advances/ (credits) to the directors	Balance outstanding
	£	£	£
Dr G Chavada	–	( 14,994)	( 14,994)
	----	--------	--------

For the period ending 30 April 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements were approved by the board of directors and authorised for issue on 10 January 2022 , and are signed on behalf of the board by:

Mr G Watson

Director

Company registration number: SC659338

The company is a private company limited by shares, registered in Scotland. The address of the registered office is Golden Jubilee National Hospital, Level 4 East, Agamemnon Street, Clydebank, G81 4DY.